Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS2 | P35228 | 2/20 | 0.50 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.40 |
| ▸ | BCAT2 | O15382 | 1/20 | 0.37 |
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.35 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.35 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.35 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.35 |
| ▸ | HTR2C | P28335 | 1/20 | 0.35 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.35 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.35 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.35 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.35 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.35 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.33 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.33 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.33 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.33 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17807492 | 0.97 | NOS2 (0.53) | NOS2MAPK10BCAT2PTGS2NR1I2 | |
| SCHEMBL12158615 | 0.83 | NOS2 (0.50) | NOS2MAPK10NISCHPTGS2ALDH1A1 | |
| SCHEMBL17807494 | 0.83 | NOS2 (0.50) | NOS2MAPK10PTGS2ALDH1A1LMNA | |
| SCHEMBL16866585 | 0.81 | MAPK10 (0.49) | NOS2MAPK10NISCHSLC6A3ALDH1A1 | |
| SCHEMBL31344191 | 0.80 | NOS2 (0.46) | NOS2NISCHCHRM1NPSR1 | |
| SCHEMBL12158623 | 0.80 | NOS2 (0.46) | NOS2NISCHADRA1AALDH1A1LMNA | |
| SCHEMBL20912486 | 0.78 | MAPK10 (0.49) | NOS2MAPK10NISCHCHRNB4CHRNA3 | |
| SCHEMBL12174623 | 0.75 | NISCH (0.45) | NOS2NISCH | |
| SCHEMBL16866584 | 0.73 | NOS2 (0.46) | NOS2NISCHHTR2CSLC6A3LMNA | |
| SCHEMBL12158625 | 0.73 | KDM4E (0.40) | NOS2NISCHPTGS2ADORA3HTR2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160164007-A1 | ORGANIC METAL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE EMPLOYING THE SAME | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2016-06-09 | — | — | US | disclosed |
| US-20160164007-A1 | ORGANIC METAL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE EMPLOYING THE SAME | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2016-06-09 | — | — | US | disclosed |
| US-20150188060-A1 | ORGANOMETALLIC COMPOUNDS AND ORGANIC ELECTROLUMINESCENCE DEVICES EMPLOYING THE SAME | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2015-07-02 | — | — | US | disclosed |
| US-20150188060-A1 | ORGANOMETALLIC COMPOUNDS AND ORGANIC ELECTROLUMINESCENCE DEVICES EMPLOYING THE SAME | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2015-07-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160164007-A1 | ORGANIC METAL COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE EMPLOYING THE SAME | C5, C9, C1S | NOS2 1101/4885MAPK10 2208/4885BCAT2 1204/4885 |
| US-20150188060-A1 | ORGANOMETALLIC COMPOUNDS AND ORGANIC ELECTROLUMINESCENCE DEVICES EMPLOYING THE SAME | DDT, DDC, BMI1 | NOS2 724/4885MAPK10 2735/4885BCAT2 71/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.